Characteristics of Streptococcus pseudopneumoniae isolated from purulent sputum samples

被引:63
作者
Keith, ER
Podmore, RG
Anderson, TP
Murdoch, DR
机构
[1] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand
[2] Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand
关键词
D O I
10.1128/JCM.44.3.923-927.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Streptococcus pseudopneumoniae is a recently described streptococcus that is phenotypically and genetically distinct from Streptococcus pneumoniae and other viridans streptococci. Key characteristics of S. pseudopneumoniae are the absence of a pneumococcal capsule, insolubility in bile, resistance or indeterminate susceptibility to optochin when incubated in 5% CO5 but susceptibility to optochin when incubated in ambient air, and a positive reaction with the AccuProbe DNA probe hybridization test. The clinical importance of this bacterium is currently unknown. We report the characteristics and associated clinical data of 35 strains of S. pseudopneumoniae isolated from sputum samples from 33 patients. All isolates produced a positive result with the NOW S. pneumoniae antigen test (Binax, Inc.). No isolate was resistant to penicillin, but 60% were resistant to erythromycin and 77% were resistant to tetracycline. All patients had lower respiratory tract symptoms, 79% had chronic obstructive pulmonary disease (COPD), and 33% had chest radiographic infiltrates. Compared with matched control patients who had Streptococcus pneumoniae isolated from sputum, patients with S. pseudopneumoniae infection were more likely to have a history of COPD (odds ratio [OR], 5.0; 95% confidence interval [CI], 1.67 to 20.11) or exacerbation of COPD (OR, 6.5; 95% CI, 2.61 to 16.20). Further research is needed to better characterize the epidemiology of S. pseudopneumoniae colonization and the role of S. pseudopneumoniae in COPD and other diseases.
引用
收藏
页码:923 / 927
页数:5
相关论文
共 12 条
[1]  
[Anonymous], [No title captured]
[2]   Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp nov. [J].
Arbique, JC ;
Poyart, C ;
Trieu-Cuot, P ;
Quesne, G ;
Carvalho, MDS ;
Steigerwalt, AG ;
Morey, RE ;
Jackson, D ;
Davidson, RJ ;
Facklam, RR .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (10) :4686-4696
[3]   Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I) [J].
Cochetti, I ;
Vecchi, M ;
Mingoia, M ;
Tili, E ;
Catania, MR ;
Manzin, A ;
Varaldo, PE ;
Montanari, MP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (12) :4999-5006
[4]  
DIAZ E, 1992, J BACTERIOL, V174, P5508
[5]  
Euzéby J, 2005, INT J SYST EVOL MICR, V55, P1403, DOI [10.1099/ijs.0.63884-0, 10.1099/ijs.0.63680-0]
[6]  
*GLOB IN CHRON OBS, 2004, NHLBI WHO WORKSH REP
[7]  
Murdoch DR, 2003, J CLIN MICROBIOL, V41, P2271, DOI 10.1128/JCM.41.5.2271.2003
[8]   Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia [J].
Murdoch, DR ;
Anderson, TP ;
Beynon, KA ;
Chua, A ;
Fleming, AM ;
Laing, RTR ;
Town, GI ;
Mills, GD ;
Chambers, ST ;
Jennings, LC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :63-66
[9]   Molecular peculiarities of the lytA gene isolated from clinical pneumococcal strains that are bile insoluble [J].
Obregón, V ;
García, P ;
García, E ;
Fenoll, A ;
López, R ;
García, JL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (07) :2545-2554
[10]   New strains of bacteria and exacerbations of chronic obstructive pulmonary disease [J].
Sethi, S ;
Evans, N ;
Grant, BJB ;
Murphy, TF .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :465-471